Benefits of Breast Cancer Index

Susan K. Boolbol, MD

Video Categories: PMO Interview with the Innovator Series: Volume 8

Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.

Related Videos

April 14, 2015

Managing Costs in Oncology Care

Dr. Boccia talks about the importance of controlling costs in the current environment and how the bioT3 testing approach can help compared to other options.

July 25, 2018

The Best Molecular Biomarkers Available for Informing Immunotherapy of Cancer

Dr David Spigel talks about currently available and emerging biomarkers that predict the greatest sensitivity to immunotherapy, including his insight into PD-L1, MSI, and TMB.